메뉴 건너뛰기




Volumn 141, Issue 4, 2006, Pages 767-769

Orbital cellulitis in a patient receiving infliximab for ankylosing spondylitis

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

EID: 33645292067     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.11.017     Document Type: Article
Times cited : (19)

References (5)
  • 1
    • 0035846326 scopus 로고    scopus 로고
    • Tuberculosis associated with infliximab, a tumor necrosis factor alpha neutralizing agent
    • J. Keane, S. Gershon, R.P. Wise Tuberculosis associated with infliximab, a tumor necrosis factor alpha neutralizing agent N Engl J Med 345 2001 1098 1104
    • (2001) N Engl J Med , vol.345 , pp. 1098-1104
    • Keane, J.1    Gershon, S.2    Wise, R.P.3
  • 2
    • 25844448786 scopus 로고    scopus 로고
    • Infliximab and reactivation of Cerebral Toxoplasmosis
    • J.D. Young, B.S. McGwire Infliximab and reactivation of Cerebral Toxoplasmosis N Engl J Med 353 2005 1530 1531
    • (2005) N Engl J Med , vol.353 , pp. 1530-1531
    • Young, J.D.1    McGwire, B.S.2
  • 3
    • 24144479466 scopus 로고    scopus 로고
    • Increased risk for demyelinating diseases in patients with inflammatory bowel disease
    • G. Gupta, J.M. Gelfand, J.D. Lewis Increased risk for demyelinating diseases in patients with inflammatory bowel disease Gastroenterology 129 2005 819 826
    • (2005) Gastroenterology , vol.129 , pp. 819-826
    • Gupta, G.1    Gelfand, J.M.2    Lewis, J.D.3
  • 4
    • 2442668848 scopus 로고    scopus 로고
    • Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease
    • W.J. Sandborn, E.V. Loftus Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease Gut 53 2004 780 782
    • (2004) Gut , vol.53 , pp. 780-782
    • Sandborn, W.J.1    Loftus, E.V.2
  • 5
    • 0344237252 scopus 로고    scopus 로고
    • Early diagnosis of pyomyositis using clinic based ultrasonography in a patient receiving infliximab therapy for Behcet's disease
    • D. Kane, P.V. Balint, F. Wood, R.D. Sturrock Early diagnosis of pyomyositis using clinic based ultrasonography in a patient receiving infliximab therapy for Behcet's disease Rheumatology (Oxford) 42 2003 261
    • (2003) Rheumatology (Oxford) , vol.42 , pp. 261
    • Kane, D.1    Balint, P.V.2    Wood, F.3    Sturrock, R.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.